Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125013052 | 12501305 | 2 | F | 20150624 | 20160620 | 20160627 | 20160701 | EXP | US-JNJFOC-20160618819 | JOHNSON AND JOHNSON | 59.51 | YR | A | F | Y | 129.50000 | KG | 20160701 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125013052 | 12501305 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
| 125013052 | 12501305 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
| 125013052 | 12501305 | 3 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | UNSPECIFIED | QD | |||||||
| 125013052 | 12501305 | 4 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 50 | MG | UNSPECIFIED | QD | |||||||
| 125013052 | 12501305 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | UNSPECIFIED | QD | |||||||
| 125013052 | 12501305 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | UNSPECIFIED | QD | |||||||
| 125013052 | 12501305 | 7 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | AS NECESSARY | 0 | 200 | MG | UNSPECIFIED | |||||||
| 125013052 | 12501305 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | UNSPECIFIED | BID | |||||||
| 125013052 | 12501305 | 9 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | 0 | 2 | DF | TABLET | ||||||||
| 125013052 | 12501305 | 10 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 0 | 200 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125013052 | 12501305 | 2 | Product used for unknown indication |
| 125013052 | 12501305 | 3 | Prophylaxis |
| 125013052 | 12501305 | 4 | Hypertension |
| 125013052 | 12501305 | 5 | Hypertension |
| 125013052 | 12501305 | 6 | Prophylaxis |
| 125013052 | 12501305 | 7 | Headache |
| 125013052 | 12501305 | 8 | Fluid retention |
| 125013052 | 12501305 | 9 | Migraine |
| 125013052 | 12501305 | 10 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125013052 | 12501305 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125013052 | 12501305 | Intentional overdose | |
| 125013052 | 12501305 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125013052 | 12501305 | 2 | 20150624 | 20150624 | 0 | |
| 125013052 | 12501305 | 3 | 201310 | 0 | ||
| 125013052 | 12501305 | 4 | 20131009 | 0 | ||
| 125013052 | 12501305 | 5 | 20131009 | 0 | ||
| 125013052 | 12501305 | 6 | 20131009 | 0 | ||
| 125013052 | 12501305 | 7 | 201311 | 0 | ||
| 125013052 | 12501305 | 8 | 20141002 | 0 | ||
| 125013052 | 12501305 | 9 | 20150119 | 0 | ||
| 125013052 | 12501305 | 10 | 20150210 | 0 |